The 5th annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the wearable injectors field, including the enhanced demand for on-body injectors and digitalised health as the need for at home self-administration and routes for delivery of time-dependent, high volume and viscous drugs grow.
The conference will also cover key regulatory updates such as guidance on MDR requirements from regulatory and notified bodies, and the importance of considering user-experience and developing patient-centric devices. The two-day conference will bring you high-quality insights and industry connections on the latest advances in wearable injectors and connectivity, and a platform for exchanging ideas.
2023 Speakers Included
- Andrew Chapman, Senior Director, AstraZeneca
- Caroline Zakrzewski, Senior Engineer, AstraZeneca
- Cedric Gysel, Manager Health Care Solutions Design, Johnson & Johnson
- Eleanor Kimber, Principal Device Engineer, GlaxoSmithKline
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Ian Wallace, Connected Health, Lead Systems Engineer, Novartis
- Ingo Herbert Waschulewski, Business Development, Gerresheimer AG
- Jacqueline Schendel, Head of Laboratory, Boehringer Ingelheim
- Julian Dixon, Senior Director, Biopharmaceutical Development - Human Factors, AstraZeneca
- Marie Picci, Delivery Systems Strategy Director, Device Development & LCM, Novartis
- Mark Milton-Edwards, Head of Health Solutions, Teva Pharmaceuticals
- Min Wei, Senior Director, AstraZeneca
- Paul Osbourne, Global Project Leader Facilitator, BioPhorum
- Paula Antunes, Global Regulatory Lead, Novo Nordisk
- Richard Crowther, Snr Manager Regulatory Affairs, Amgen
- Sabine Kattenbeck, Head of Device Project Management, Boehringer Ingelheim Pharma GmbH & Co. KG
- Simon Wilson, Device Development Lead, Pfizer
- Soren Skov, Senior Human Factors Engineer, Roche
- Thomas Wejs Moeller, Director Global Regulatory Affairs - Device, Novo Nordisk
The full agenda is not yet available for this event.
Follow this event to receive an alert when the agenda becomes available.
Venue
Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK
